Jazz Pharmaceuticals PLC banner

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 183.73 USD 0.94%
Market Cap: $11.3B

Wall Street
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 223.78 USD with a low forecast of 189.88 USD and a high forecast of 276.15 USD.

Lowest
Price Target
189.88 USD
3% Upside
Average
Price Target
223.78 USD
22% Upside
Highest
Price Target
276.15 USD
50% Upside
Jazz Pharmaceuticals PLC Competitors:
Price Targets
SPH
Suburban Propane Partners LP
-15% Downside

Revenue
Forecast

23% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
23% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 23%. The projected CAGR for the next 4 years is 7%.

Operating Income
Forecast

14% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-43%
Average Miss
14% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-43%
Average Miss

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 14%. The projected CAGR for the next 4 years is 30%.

Net Income
Forecast

12% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss
12% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 12%. The projected CAGR for the next 4 years is 31%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAZZ's stock price target?
Price Target
223.78 USD

According to Wall Street analysts, the average 1-year price target for JAZZ is 223.78 USD with a low forecast of 189.88 USD and a high forecast of 276.15 USD.

What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 23%. The projected CAGR for the next 4 years is 7%.

What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
30%

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 14%. The projected CAGR for the next 4 years is 30%.

What is Jazz Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
31%

For the last 13 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 12%. The projected CAGR for the next 4 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett